WallStreetZenWallStreetZen

NASDAQ: ZYXI
Zynex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZYXI

Based on 2 analysts offering 12 month price targets for Zynex Inc.
Min Forecast
$15.00+33.57%
Avg Forecast
$18.00+60.28%
Max Forecast
$21.00+87%

Should I buy or sell ZYXI stock?

Based on 2 analysts offering ratings for Zynex Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ZYXI stock forecasts and price targets.

ZYXI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is ZYXI forecast to generate an efficient return?
Company
66.95%
Industry
141.2%
Market
33.08%
ZYXI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZYXI forecast to generate an efficient return on assets?
Company
22.56%
Industry
4.2%
ZYXI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZYXI revenue forecast

What is ZYXI's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$228.0M+23.7%

ZYXI vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
ZYXI$11.23$18.00+60.28%Buy
EDAP$6.84$9.00+31.58%Strong Buy
AHG$0.77N/AN/A
OMI$24.74$24.00-2.99%Hold
PDCO$26.18$32.20+22.99%Hold
View Top Medical Distribution Stocks

Zynex Stock Forecast FAQ

Is Zynex Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ZYXI) stock is to Buy ZYXI stock.

Out of 2 analysts, 0 (0%) are recommending ZYXI as a Strong Buy, 2 (100%) are recommending ZYXI as a Buy, 0 (0%) are recommending ZYXI as a Hold, 0 (0%) are recommending ZYXI as a Sell, and 0 (0%) are recommending ZYXI as a Strong Sell.

If you're new to stock investing, here's how to buy Zynex stock.

What is ZYXI's revenue growth forecast for 2024-2024?

(NASDAQ: ZYXI) Zynex's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Zynex's revenue in 2024 is $184,322,000.

In 2024, ZYXI is forecast to generate $7,334,801,496 in revenue, with the lowest revenue forecast at $7,334,801,496 and the highest revenue forecast at $7,334,801,496.

What is ZYXI's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: ZYXI) forecast ROA is 22.56%, which is higher than the forecast US Medical Distribution industry average of 4.2%.

What is ZYXI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ZYXI price target, the average ZYXI price target is $18.00, with the highest ZYXI stock price forecast at $21.00 and the lowest ZYXI stock price forecast at $15.00.

On average, Wall Street analysts predict that Zynex's share price could reach $18.00 by Mar 1, 2025. The average Zynex stock price prediction forecasts a potential upside of 60.28% from the current ZYXI share price of $11.23.

What is ZYXI's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: ZYXI) forecast ROE is 66.95%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.